Novus Biologicals products are now on bio-techne.com

Siglec-2/CD22 Products

Antibodies
Siglec-2/CD22 Antibody (2H1C4 ...
Siglec-2/CD22 Antibody (2H1C4) - B...
Species: Hu
Applications: WB, ELISA, Flow, ICC/IF, IHC
Host: Mouse Monoclonal
Formulation Catalog # Availability Price  
ELISA Kits
Human Siglec-2/CD22 DuoSet EL ...
Human Siglec-2/CD22 DuoSet ELISA, ...
DY1968-05
Species: Hu
Applications: ELISA
Proteins
Recombinant Human Siglec-2/CD ...
Recombinant Human Siglec-2/CD22 Fc...
1968-SL
Species: Hu
Applications: Bioactivity
Formulation Catalog # Availability Price  
Recombinant Mouse Siglec-2/CD ...
Recombinant Mouse Siglec-2/CD22 Fc...
2296-SL
Species: Mu
Applications: Bioactivity
Formulation Catalog # Availability Price  
Recombinant Human Siglec-2/CD ...
Recombinant Human Siglec-2/CD22 Fc...
AVI1968
Species: Hu
Applications: Bioactivity
Conjugate Catalog # Availability Size Price
Formulation Catalog # Availability Price  

Description

CD22 is a single-pass type 1 membrane glycoprotein found in the cytoplasm and cell membrane of B-lymphocytes. CD22 has at least two isoforms (alpha and beta) produced by alternate splicing. The protein exists predominantly as a monomer of the beta isoform (95 kDa). It is also found as a heterodimer of the beta and alpha isoforms.

Bioinformatics

Entrez Mouse
Human
Uniprot Human
Human
Product By Gene ID 933
Alternate Names
  • B-cell receptor CD22
  • BL-CAM
  • B-lymphocyte cell adhesion molecule
  • CD22 antigenMGC130020
  • CD22 molecule
  • sialic acid binding Ig-like lectin 2
  • Sialic acid-binding Ig-like lectin 2
  • Siglec-2
  • SIGLEC-2
  • SIGLEC2FLJ22814
  • T-cell surface antigen Leu-14

Research Areas for Siglec-2/CD22

Find related products by research area and learn more about each of the different research areas below.

Adaptive Immunity
CD Markers
DNA Repair
Immunology
Phospho-Specific

Related Siglec-2/CD22 Blog Posts

Check out the latest blog posts on Siglec-2/CD22.
Antigen-loss relapse after successful CAR-T therapy; What do we do now?
By Jacqueline Carrico, BS, MD Tumor cell mechanisms driving tolerance to CAR-T Despite very promising results of CAR-T therapy in acute lymphoblastic leukemia, B-ALL, antigen-loss relapse has arisen as a major chall...    Read more.
Read more Siglec-2/CD22 related blogs.